10 employees
Neoantigenics is a liability company that focuses on developing oncology theranostics.
2012
$2.5M
from 2 investors over 2 rounds
Neoantigenics, Inc. raised $2.5M on January 15, 2015
Investors: IrishAngels
Neoantigenics, Inc. raised undisclosed on April 13, 2014
Investors: Virginia Venture Partners